Education
About Us
Working with TipRanks
Follow Us
Alpha Teknova, Inc. (TKNO)
:TKNO
TKNO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.16 - $10.37
Previous CloseN/A
Volume51.57K
Average Volume (3M)380.18K
Market Cap
$294.97M
Enterprise Value$249.71M
Total Cash (Recent Filing)-$9.68M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.61
Next Earnings
May 07, 2025EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding53,436,806
10 Day Avg. Volume571,303
30 Day Avg. Volume380,175
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.93
Price to Cash Flow (P/CF)-39.40
P/FCF Ratio0.00
Enterprise Value/Market Cap0.85
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit34.53
Enterprise Value/Ebitda-9.82
Forecast
1Y Price Target
$11.00Price Target Upside80.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
---
Alpha Teknova News
PremiumCompany Announcements
Alpha Teknova’s Earnings Call: Growth Amid Challenges
---
Bulls Say, Bears Say
Bulls Say
Customer GrowthTeknova ended 2024 with a 41% increase in clinical solutions customers and an 8% increase in lab essentials customers.
Financial PerformanceQ4 revenues of $9.3M beat the Street's $8.8M, showing stronger than expected performance.
Bears Say
Revenue Guidance2025 revenue guidance of $39-42M is below consensus estimates, leading to modest expected top line growth.
---
Ownership Overview
50.81% Insiders
1.65% Mutual Funds
2.26% Other Institutional Investors
42.34% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TKNO FAQ
What was Alpha Teknova, Inc.’s price range in the past 12 months?
Alpha Teknova, Inc. lowest stock price was $1.16 and its highest was $10.37 in the past 12 months.
What is Alpha Teknova, Inc.’s market cap?
Alpha Teknova, Inc.’s market cap is $294.97M.
When is Alpha Teknova, Inc.’s upcoming earnings report date?
Alpha Teknova, Inc.’s upcoming earnings report date is May 07, 2025 which is in 56 days.
How were Alpha Teknova, Inc.’s earnings last quarter?
Alpha Teknova, Inc. released its earnings results on Mar 04, 2025. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.12 by $0.01.
Is Alpha Teknova, Inc. overvalued?
According to Wall Street analysts Alpha Teknova, Inc.’s price is currently Undervalued.
Does Alpha Teknova, Inc. pay dividends?
Alpha Teknova, Inc. does not currently pay dividends.
What is Alpha Teknova, Inc.’s EPS estimate?
Alpha Teknova, Inc.’s EPS estimate is -0.11.
How many shares outstanding does Alpha Teknova, Inc. have?
Alpha Teknova, Inc. has 53,436,806 shares outstanding.
What happened to Alpha Teknova, Inc.’s price movement after its last earnings report?
Alpha Teknova, Inc. reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.12. Following the earnings report the stock price went down -1.159%.
Which hedge fund is a major shareholder of Alpha Teknova, Inc.?
Currently, no hedge funds are holding shares in TKNO
---
Alpha Teknova Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (80.62% Upside)
$11.00 (80.62% Upside)
Hedge Fund Trend
Decreased
By 531.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 3.5%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
93.68%
12-Months-Change
Fundamentals
Return on Equity
-31.02%
Trailing 12-Months
Asset Growth
-7.64%
Trailing 12-Months
Company Description
Alpha Teknova, Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification.
---
TKNO Company Deck
---
TKNO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant growth in clinical customers and key segments like custom biopharma while also noting improvements in operational efficiency and cash flow. However, challenges included flat overall revenue growth, a decline in gross margins, and market-specific hurdles that tempered the company's outlook.Read More>---
TKNO Stock 12 Month Forecast
Average Price Target
$11.00
▲(80.62% Upside)
Technical Analysis
Best Analysts Covering TKNO
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
-6.07%
reiterated a buy rating 7 days ago
Copying Matt Larew's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -6.07% per trade.
---